Financials Scientific and Medical Equipment House Company

Equities

4014

SA15GGQ1UN19

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. 13:20:03 12/05/2024 BST 5-day change 1st Jan Change
53 SAR +1.15% Intraday chart for Scientific and Medical Equipment House Company +1.73% +10.99%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 1,222 1,432 1,590 - -
Enterprise Value (EV) 1 1,222 1,432 1,590 1,590 1,590
P/E ratio - - - - -
Yield - - 1.89% 1.89% 2.08%
Capitalization / Revenue 1.71 x 1.79 x 1.63 x 1.48 x 1.38 x
EV / Revenue 1.71 x 1.79 x 1.63 x 1.48 x 1.38 x
EV / EBITDA - 17,547,646 x - - -
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - - - -
Nbr of stocks (in thousands) 30,000 30,000 30,000 - -
Reference price 2 40.73 47.75 53.00 53.00 53.00
Announcement Date 09/04/23 02/04/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 713.8 799.3 978 1,077 1,153
EBITDA - - 81.63 - - -
EBIT 1 - 37.51 68.65 76 85 96
Operating Margin - 5.25% 8.59% 7.77% 7.89% 8.33%
Earnings before Tax (EBT) - - - - - -
Net income 77.52 - - - - -
Net margin - - - - - -
EPS 2.587 - - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - 1.000 1.000 1.100
Announcement Date 07/04/22 09/04/23 02/04/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 164.9 190.8 211.8 231.8 231
EBITDA - - - - -
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income - 1.436 - 13.59 -
Net margin - 0.75% - 5.86% -
EPS - - - - -
Dividend per Share - - - - -
Announcement Date 24/05/23 17/08/23 09/11/23 02/04/24 -
1SAR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - 9.7% 11.5% 12.9%
ROA (Net income/ Total Assets) - - - 6.9% 6.9% -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 07/04/22 09/04/23 02/04/24 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
53 SAR
Average target price
46 SAR
Spread / Average Target
-13.21%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4014 Stock
  4. Financials Scientific and Medical Equipment House Company